Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Zosuquidar (LY335979) is an inhibitor of P-glycoprotein with a Ki value of 59 nM. Zosuquidar has anti-tumor activities, and can be used in acute myelogenous leukemia (AML) research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,298.00 | |
50 mg | 8-10 weeks | $ 1,918.00 | |
100 mg | 8-10 weeks | $ 2,455.00 |
Description | Zosuquidar (LY335979) is an inhibitor of P-glycoprotein with a Ki value of 59 nM. Zosuquidar has anti-tumor activities, and can be used in acute myelogenous leukemia (AML) research. |
Molecular Weight | 527.6 |
Formula | C32H31F2N3O2 |
CAS No. | 167354-41-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Zosuquidar 167354-41-8 inhibitor inhibit